AbbVie Financials
| 4AB Stock | EUR 167.00 0.02 0.01% |
AbbVie |
Understanding current and past AbbVie Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of AbbVie's financial statements are interrelated, with each one affecting the others. For example, an increase in AbbVie's assets may result in an increase in income on the income statement.
AbbVie Stock Summary
AbbVie competes with PENN NATL, FUTURE GAMING, GigaMedia, EAST SIDE, and ANGLER GAMING. AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products in the United States, Japan, Germany, Canada, Italy, Spain, the Netherlands, the United Kingdom, Brazil, and internationally. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois. ABBVIE INC operates under Drug Manufacturers - Major classification in Germany and is traded on Frankfurt Stock Exchange. It employs 30000 people.| Instrument | Germany Stock View All |
| Exchange | Frankfurt Exchange |
| ISIN | US00287Y1091 |
| Business Address | 1 North Waukegan |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Major |
| Benchmark | Dow Jones Industrial |
| Website | www.abbvie.com |
| Phone | 847 932 7900 |
| Currency | EUR - Euro |
You should never invest in AbbVie without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of AbbVie Stock, because this is throwing your money away. Analyzing the key information contained in AbbVie's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
AbbVie Key Financial Ratios
There are many critical financial ratios that AbbVie's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that AbbVie Inc reports annually and quarterly.| Return On Equity | 0.72 | |||
| Return On Asset | 0.0991 | |||
| Target Price | 127.01 | |||
| Beta | 0.58 | |||
| Z Score | 2.4 |
AbbVie Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining AbbVie's current stock value. Our valuation model uses many indicators to compare AbbVie value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across AbbVie competition to find correlations between indicators driving AbbVie's intrinsic value. More Info.AbbVie Inc is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.14 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for AbbVie Inc is roughly 7.30 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the AbbVie's earnings, one of the primary drivers of an investment's value.AbbVie Inc Systematic Risk
AbbVie's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. AbbVie volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on AbbVie Inc correlated with the market. If Beta is less than 0 AbbVie generally moves in the opposite direction as compared to the market. If AbbVie Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one AbbVie Inc is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of AbbVie is generally in the same direction as the market. If Beta > 1 AbbVie moves generally in the same direction as, but more than the movement of the benchmark.
AbbVie December 12, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of AbbVie help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of AbbVie Inc. We use our internally-developed statistical techniques to arrive at the intrinsic value of AbbVie Inc based on widely used predictive technical indicators. In general, we focus on analyzing AbbVie Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build AbbVie's daily price indicators and compare them against related drivers.
| Information Ratio | (0.08) | |||
| Maximum Drawdown | 19.0 | |||
| Value At Risk | (2.05) | |||
| Potential Upside | 3.16 |
Complementary Tools for AbbVie Stock analysis
When running AbbVie's price analysis, check to measure AbbVie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AbbVie is operating at the current time. Most of AbbVie's value examination focuses on studying past and present price action to predict the probability of AbbVie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AbbVie's price. Additionally, you may evaluate how the addition of AbbVie to your portfolios can decrease your overall portfolio volatility.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |